Medivir AB Series B | Cash Flow
Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
34
1,189
102
283
360
350
Depreciation, Depletion & Amortization
33
33
40
33
30
26
Other Funds
1
205
11
506
17
34
Funds from Operations
67
1,016
131
190
347
291
Changes in Working Capital
24
2
216
7
12
28
Net Operating Cash Flow
43
1,014
347
182
358
319
Capital Expenditures
4
20
20
106
14
Sale of Fixed Assets & Businesses
115
3
5
910
-
Net Investing Cash Flow
111
18
15
803
14
Issuance/Reduction of Debt, Net
49
-
40
-
-
Net Financing Cash Flow
49
-
652
-
859
Net Change in Cash
105
993
318
621
1,231
Free Cash Flow
39
1,005
337
192
359
Change in Capital Stock
-
-
612
-
859
Exchange Rate Effect
-
3
2
-
-
About Medivir AB
View Profile
